Indication
Osteoporosis
Osteoporosis is a systemic skeletal disorder characterized by low bone mass, deterioration of bone microarchitecture, and increased bone fragility. Read more about Osteoporosis
323 drugs 93 manufacturers
Drugs that treat it
Common Osteoporosis therapies.
CALCIUM CITRATE-VITAMIN D3 (calcium citrate/cholecalciferol (vitamin D3))
MAXIMUM D3 (cholecalciferol (vitamin D3))
CALCIUM 600 + D(3) (calcium carbonate/cholecalciferol (vitamin D3))
CALCIUM CARBONATE/VITAMIN D3 (calcium carbonate/cholecalciferol (vitamin D3))
CALCIUM (calcium carbonate/cholecalciferol (vit D3)/vit K1)
OYSTER SHELL-D (calcium carbonate/cholecalciferol (vitamin D3))
CA-D3-MAG-ZINC-COP-MANG-BOR (calcium carbonate/vit D3/mag ox/zinc/copper/manganese/boron)
CALCIUM 500-VIT D3 (calcium carbonate/cholecalciferol (vitamin D3))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOsteoporosis is a systemic skeletal disorder characterized by low bone mass, deterioration of bone microarchitecture, and increased bone fragility.
Although it can affect individuals of any age or sex, it most commonly arises in postmenopausal women and older adults due to age-related bone loss, estrogen deficiency, or secondary causes such as chronic glucocorticoid therapy and endocrine disorders.
Pathophysiologically, an imbalance where osteoclast-mediated bone resorption outpaces osteoblast-mediated bone formation leads to diminished bone mineral density and compromised mechanical strength.
Often clinically silent until a low-energy trauma occurs, it predisposes patients to pathological fragility fractures, most frequently involving the spine, hip, and wrist.
- nih.gov
Osteoporosis is a systemic skeletal disorder characterized by low bone mass, deterioration of bone microarchitecture, and increased bone fragility Although it can affect individuals of any age or sex, it most commonly arises in postmenopausal women and older adults due to age-related bone loss, estrogen deficiency, or secondary causes such as chronic glucocorticoid therapy and endocrine disorders Pathophysiologically, an imbalance where osteoclast-mediated bone resorption outpaces osteoblast-med...
- nih.gov
Osteoporosis is a systemic skeletal disorder characterized by low bone mass, deterioration of bone microarchitecture, and increased bone fragility Although it can affect individuals of any age or sex, it most commonly arises in postmenopausal women and older adults due to age-related bone loss, estrogen deficiency, or secondary causes such as chronic glucocorticoid therapy and endocrine disorders Often clinically silent until a low-energy trauma occurs, it predisposes patients to pathological fr...
- nih.gov
Although it can affect individuals of any age or sex, it most commonly arises in postmenopausal women and older adults due to age-related bone loss, estrogen deficiency, or secondary causes such as chronic glucocorticoid therapy and endocrine disorders Pathophysiologically, an imbalance where osteoclast-mediated bone resorption outpaces osteoblast-mediated bone formation leads to diminished bone mineral density and compromised mechanical strength Often clinically silent until a low-energy trauma...
Personalize your experience
Follow Osteoporosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.